| PML nuclear bodies |
None |
PML (Tatham et al., 2008), SP100 and TDG (Sahin et al., 2014), DAXX (Lin et al., 2006), HIPK2 (Sung et al., 2019), p53 (Ivanschitz et al., 2015), CBP (Ryan et al., 2010), ATRX (Correa-Vázquez et al., 2021), MRE11 (Sohn & Hearing, 2012) |
| ALT-associated PML bodies (APBs) |
None |
TRF1 (Yu et al., 2007), TRF2 (Zhang et al., 2021), RPA (Dou et al., 2010), MRE11 (Sohn & Hearing, 2012), WRN (Kawabe et al., 2000), BRCA1 (Vialter et al., 2011), XRCC3 (Hu et al., 2018), PRB (Ledl et al., 2005), TPZ1 (Garg et al., 2014), 53BP1 (Galanty et al., 2009), RIF1 (Kumar & Cheok, 2017), HNRNPA2 (Vassileva & Matunis, 2004), HP1Α, HP1Β and HP1γ (Maison et al., 2016), ATM and ATR (Munk et al., 2017), FANCA and FANCD2 (Coleman & Huang, 2016), SLX4 and FEN1 (Yalçin et al., 2017), γ-H2AX (Chen et al., 2013), MDC1 (Luo et al., 2012), MUS81 (Hu et al., 2017), NXP2 (Mimura et al., 2010), PARP1 (Zilio et al., 2013), POT1 (Singh et al., 2013), RAD51 (Shima et al., 2013), RAD52 and PCAN (Silva et al., 2016), BLM (Min et al., 2019), SMC5/6 (Varejão et al., 2018), TOPOIIΑ (Ryu et al., 2010), PML (Sahin et al., 2014), p53 (Schmidt & Müller, 2002), SP100 (Guion et al., 2019), DAXX (Jang et al., 2002), RAP1 (Chymkowitch et al., 2015) |
| DNA damage foci |
Rfa1, Rad59 (Burgess et al., 2007), Sgs1, Top3 (Bonner et al., 2016), Top2 (Yoshida & Azuma, 2016), H2A.Z and Yku70/Yku80 (Kalocsay et al., 2009), PCNA (Li et al., 2018), Yen1 (Talhaoui et al., 2018), Rad52 (Su et al., 2015), Srs2 (Kramarz et al., 2017), DDK (Psakhye et al., 2019), Mms4 (Waizenegger et al., 2020) |
PCNA (Gali et al., 2012), BRCA1 (Vyas et al., 2013), RPA1 (Galanty et al., 2012), 53BP1 (Groocock et al., 2014), XRCC4 (Yurchenko et al., 2006), XRCC5 (Kumar et al., 2017), KU70/KU80 (Yurchenko et al., 2008), RAD51 (Hariharasudhan et al., 2022), MDC1 (Galanty et al., 2012), FANCA (Xie et al., 2015), FANCE (Xie et al., 2015), FANCD2 (Gibbs-Seymour et al., 2015), BLM (Kumar et al., 2017), RAD18 (Kumar et al., 2017), ERCC1 (Guervilly et al., 2015), SLX4 (Guervilly et al., 2015), RAP1 (Chymkowitch et al., 2015), KAP1 (Bürck et al., 2015), CTIP (Locke et al., 2021) |
| Nucleolus |
Tof2, Net1, Cdc14 (de Albuquerque et al., 2016; Liang et al., 2017), Fob1 (Gillies et al., 2016), Sir2 (Hannan et al., 2015), Nur1 (Capella et al., 2021), Lrs4 (Capella et al., 2021) |
DKC1 (Manza et al., 2004; Westman et al., 2010), NHP2 (Blomster et al., 2009; Westman et al., 2010), NOLC1 (Golebiowski et al., 2009; Westman et al., 2010), NOP58 (Westman et al., 2010; Westman & Lamond, 2011), DDB2 (Vertegaal et al., 2006; Westman et al., 2010), DDX21 (Matafora et al., 2009; Westman et al., 2010), TFRC and NFIX (Golebiowski et al., 2009; Westman et al., 2010), ALPL ALPP, CAV1, CYB5B, PDLIM7, KLHDC3, FHL1, PRMT5, LSS, RDH10, and EXOSC10 (Westman et al., 2010). |
